1,144
Views
15
CrossRef citations to date
0
Altmetric
Research Paper

Safety and immunogenicity of a live attenuated mumps vaccine

A phase I clinical trial

, , , , , , , , , , , , , , , , , , , , & show all
Pages 1382-1390 | Received 13 Dec 2013, Accepted 24 Feb 2014, Published online: 10 Mar 2014

References

  • Mühlemann K. The molecular epidemiology of mumps virus. Infect Genet Evol 2004; 4:215 - 9; http://dx.doi.org/10.1016/j.meegid.2004.02.003; PMID: 15450201
  • Hviid A, Rubin S, Mühlemann K. Mumps. Lancet 2008; 371:932 - 44; http://dx.doi.org/10.1016/S0140-6736(08)60419-5; PMID: 18342688
  • Centers for Disease Control and Prevention (CDC). Notice to readers: updated recommendations of the Advisory Committee on Immunization Practices (ACIP) for the control and elimination of mumps. MMWR Morb Mortal Wkly Rep 2006; 55:629 - 30; PMID: 16761359
  • Control CfD. Mumps vaccine. MMWR Morb Mortal Wkly Rep 1977; 26:393 - 4
  • Watson JC, Hadler SC, Dykewicz CA, Reef S, Phillips L. Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1998; 47:RR-8 1 - 57; PMID: 9639369
  • Jajosky RA, Hall PA, Adams DA, Dawkins FJ, Sharp P, Anderson WJ, Aponte JJ, Jones GF, Nitschke DA, Worsham CA, et al, Centers for Disease Control and Prevention (CDC). Summary of notifiable diseases--United States, 2004. MMWR Morb Mortal Wkly Rep 2006; 53:1 - 79; PMID: 16775578
  • Control CfD. The statutory reporting of infectious diseases. 2002.
  • Centers for Disease Control and Prevention (CDC). Update: mumps outbreak - New York and New Jersey, June 2009-January 2010. MMWR Morb Mortal Wkly Rep 2010; 59:125 - 9; PMID: 20150887
  • Deeks SL, Lim GH, Simpson MA, Gagné L, Gubbay J, Kristjanson E, Fung C, Crowcroft NS. An assessment of mumps vaccine effectiveness by dose during an outbreak in Canada. CMAJ 2011; 183:1014 - 20; http://dx.doi.org/10.1503/cmaj.101371; PMID: 21576295
  • Gemmill IM. Mumps vaccine: is it time to re-evaluate our approach?. CMAJ 2006; 175:491 - 2; http://dx.doi.org/10.1503/cmaj.060900; PMID: 16940268
  • Ogbuanu IU, Kutty PK, Hudson JM, Blog D, Abedi GR, Goodell S, Lawler J, McLean HQ, Pollock L, Rausch-Phung E, et al. Impact of a third dose of measles-mumps-rubella vaccine on a mumps outbreak. Pediatrics 2012; 130:e1567 - 74; http://dx.doi.org/10.1542/peds.2012-0177; PMID: 23129075
  • Yang W, Xu W, Xu F, Chen Z. Sequence research on S79 strain of mumps virus during the successive passaging. Chinese Journal of Vaccines and Immunization 2007; 13:150 - 7
  • Chen Z. Mumps virus and vaccine. Chinese Journal of Vaccies and Immunization 2004; 10:120 - 3
  • Liu S, Huang Y, Chen X. The Immune Effects Analysis of Mumps Vaccine Preparated with Different Strain. S China J Prev Med 2005; 31:39 - 42
  • Dayan GH, Quinlisk MP, Parker AA, Barskey AE, Harris ML, Schwartz JM, Hunt K, Finley CG, Leschinsky DP, O’Keefe AL, et al. Recent resurgence of mumps in the United States. N Engl J Med 2008; 358:1580 - 9; http://dx.doi.org/10.1056/NEJMoa0706589; PMID: 18403766
  • Santos CL, Ishida MA, Foster PG, Sallum MA, Benega MA, Borges DB, Corrêa KO, Constantino CR, Afzal MA, Paiva TM. Detection of a new mumps virus genotype during parotitis epidemic of 2006-2007 in the state of São Paulo, Brazil. J Med Virol 2008; 80:323 - 9; http://dx.doi.org/10.1002/jmv.21068; PMID: 18098149
  • Johansson B, Tecle T, Orvell C. Proposed criteria for classification of new genotypes of mumps virus. Scand J Infect Dis 2002; 34:355 - 7; http://dx.doi.org/10.1080/00365540110080043; PMID: 12069019
  • Wu L, Bai Z, Li Y, Rima BK, Afzal MA. Wild type mumps viruses circulating in China establish a new genotype. Vaccine 1998; 16:281 - 5; http://dx.doi.org/10.1016/S0264-410X(97)00173-4; PMID: 9607043
  • Rubin SA, Link MA, Sauder CJ, Zhang C, Ngo L, Rima BK, Duprex WP. Recent mumps outbreaks in vaccinated populations: no evidence of immune escape. J Virol 2012; 86:615 - 20; http://dx.doi.org/10.1128/JVI.06125-11; PMID: 22072778
  • Peltola H, Kulkarni PS, Kapre SV, Paunio M, Jadhav SS, Dhere RM. Mumps outbreaks in Canada and the United States: time for new thinking on mumps vaccines. Clin Infect Dis 2007; 45:459 - 66; http://dx.doi.org/10.1086/520028; PMID: 17638194
  • Galazka AM, Robertson SE, Kraigher A. Mumps and mumps vaccine: a global review. Bull World Health Organ 1999; 77:3 - 14; PMID: 10063655
  • Kulkarni-Kale U, Ojha J, Manjari GS, Deobagkar DD, Mallya AD, Dhere RM, Kapre SV. Mapping antigenic diversity and strain specificity of mumps virus: a bioinformatics approach. Virology 2007; 359:436 - 46; http://dx.doi.org/10.1016/j.virol.2006.09.040; PMID: 17081582
  • Schwarzer S, Reibel S, Lang AB, Struck MM, Finkel B, Gerike E, Tischer A, Gassner M, Glück R, Stück B, et al. Safety and characterization of the immune response engendered by two combined measles, mumps and rubella vaccines. Vaccine 1998; 16:298 - 304; http://dx.doi.org/10.1016/S0264-410X(97)00174-6; PMID: 9607046
  • Hilleman MR, Weibel RE, Buynak EB, Stokes J Jr., Whitman JE Jr.. Live attenuated mumps-virus vaccine. IV. Protective efficacy as measured in a field evaluation. N Engl J Med 1967; 276:252 - 8; http://dx.doi.org/10.1056/NEJM196702022760502; PMID: 6016061
  • Chamot E, Toscani L, Egger P, Germann D, Bourquin C. [Estimation of the efficacy of three strains of mumps vaccines during an epidemic of mumps in the Geneva canton (Switzerland)]. Rev Epidemiol Sante Publique 1998; 46:100 - 7; PMID: 9592852
  • Peltola H, Davidkin I, Paunio M, Valle M, Leinikki P, Heinonen OP. Mumps and rubella eliminated from Finland. JAMA 2000; 284:2643 - 7; http://dx.doi.org/10.1001/jama.284.20.2643; PMID: 11086376
  • Vesikari T, André FE, Simoen E, Florent G, Ala-Laurila EL, Heikkinen A, Kuusinen H, Terho A. Comparison of the Urabe Am 9-Schwarz and Jeryl Lynn-Moraten combinations of mumps-measles vaccines in young children. Acta Paediatr Scand 1983; 72:41 - 6; http://dx.doi.org/10.1111/j.1651-2227.1983.tb09661.x; PMID: 6344551
  • Ong G, Goh KT, Ma S, Chew SK. Comparative efficacy of Rubini, Jeryl-Lynn and Urabe mumps vaccine in an Asian population. J Infect 2005; 51:294 - 8; http://dx.doi.org/10.1016/j.jinf.2004.10.001; PMID: 16291282
  • Schlegel M, Osterwalder JJ, Galeazzi RL, Vernazza PL. Comparative efficacy of three mumps vaccines during disease outbreak in Eastern Switzerland: cohort study. BMJ 1999; 319:352; http://dx.doi.org/10.1136/bmj.319.7206.352; PMID: 10435956
  • Wang S, Gu Z, Zhang Y, Liu H, Xie G. Comparison of HI antibody titer of local monovalent mumps vaccine and the imported MMR vaccine in previously immunized pupil. Progress in Microbiology and Immunology 1998; 26:51 - 2
  • Lewis JE, Chernesky MA, Rawls ML, Rawls WE. Epidemic of mumps in a partially immune population. Can Med Assoc J 1979; 121:751 - 4; PMID: 519614
  • Harling R, White JM, Ramsay ME, Macsween KF, van den Bosch C. The effectiveness of the mumps component of the MMR vaccine: a case control study. Vaccine 2005; 23:4070 - 4; http://dx.doi.org/10.1016/j.vaccine.2004.10.020; PMID: 15950329
  • Hersh BS, Fine PE, Kent WK, Cochi SL, Kahn LH, Zell ER, Hays PL, Wood CL. Mumps outbreak in a highly vaccinated population. J Pediatr 1991; 119:187 - 93; http://dx.doi.org/10.1016/S0022-3476(05)80726-7; PMID: 1861205
  • Liang Y, Ma S, Liu L, Zhao H, Wang L, Jiang L, Xie Z, Dong C, Li Q. Identification and development of a promising novel mumps vaccine candidate strain. Microbes Infect 2010; 12:1178 - 87; http://dx.doi.org/10.1016/j.micinf.2010.08.004; PMID: 20800105
  • Boddicker JD, Rota PA, Kreman T, Wangeman A, Lowe L, Hummel KB, Thompson R, Bellini WJ, Pentella M, Desjardin LE. Real-time reverse transcription-PCR assay for detection of mumps virus RNA in clinical specimens. J Clin Microbiol 2007; 45:2902 - 8; http://dx.doi.org/10.1128/JCM.00614-07; PMID: 17652480
  • Mauldin J, Carbone K, Hsu H, Yolken R, Rubin S. Mumps virus-specific antibody titers from pre-vaccine era sera: comparison of the plaque reduction neutralization assay and enzyme immunoassays. J Clin Microbiol 2005; 43:4847 - 51; http://dx.doi.org/10.1128/JCM.43.9.4847-4851.2005; PMID: 16145156
  • Weibel RE, Buynak EB, Whitman JE Jr., Leagus MB, Stokes J Jr., Hilleman MR. Jeryl Lynn strain live mumps virus vaccine. Durable immunity for three years following vaccination. JAMA 1969; 207:1667 - 70; http://dx.doi.org/10.1001/jama.1969.03150220083008; PMID: 5818350

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.